Literature DB >> 8490072

Autoantibodies to DNA in multicase families with schizophrenia.

P Sirota1, M A Firer, K Schild, A Tanay, A Elizur, D Meytes, H Slor.   

Abstract

In an attempt to define the autoimmune status of members of multicase families with schizophrenia, sera of both patients and healthy relatives from 28 such cases were tested for antinuclear antibodies, anti-double-stranded DNA, and anti-single-stranded DNA autoantibodies. These autoantibodies were significantly more frequent in both schizophrenic patients and healthy relatives than in normal subjects. Immunoglobulin (Ig) M anti-DNA antibodies were more common in patients, whereas in healthy relatives, IgG anti-DNA antibodies were more common. No significant differences were found between schizophrenic patients and their healthy relatives. The data indicate that an autoimmune process may be involved in the etiology of a subset of patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490072     DOI: 10.1016/0006-3223(93)90173-b

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  Anticardiolipin antibodies are elevated in drug-free, multiply affected families with schizophrenia.

Authors:  M Firer; P Sirota; K Schild; A Elizur; H Slor
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

Review 2.  Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease.

Authors:  Irina A Pashnina; Irina M Krivolapova; Tamara V Fedotkina; Varvara A Ryabkova; Margarita V Chereshneva; Leonid P Churilov; Valeriy A Chereshnev
Journal:  Antibodies (Basel)       Date:  2021-02-25

Review 3.  Proteomic profiling in schizophrenia: enabling stratification for more effective treatment.

Authors:  Paul C Guest; Daniel Martins-de-Souza; Emanuel Schwarz; Hassan Rahmoune; Murtada Alsaif; Jakub Tomasik; Christoph W Turck; Sabine Bahn
Journal:  Genome Med       Date:  2013-03-26       Impact factor: 11.117

4.  The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study.

Authors:  Hans C van Mierlo; Lot de Witte; Ronald Hwm Derksen; Henny G Otten
Journal:  NPJ Schizophr       Date:  2015-05-06

5.  Natural Catalytic IgGs Hydrolyzing Histones in Schizophrenia: Are They the Link between Humoral Immunity and Inflammation?

Authors:  Evgeny A Ermakov; Daria A Parshukova; Georgy A Nevinsky; Valentina N Buneva
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.